Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis

被引:0
作者
Parisotto, R
Wu, MT
Ashenden, MJ
Emslie, KR
Gore, CJ
Howe, C
Kazlauskas, R
Sharpe, K
Trout, GJ
Xie, MH
Hahn, AG
机构
[1] Australian Inst Sport, Dept Physiol, Canberra, ACT 2616, Australia
[2] China Doping Control Ctr, Beijing, Peoples R China
[3] Australian Govt Analyt Labs, ASDTL, Sydney, NSW, Australia
[4] Univ Melbourne, Dept Math & Stat, Melbourne, Vic, Australia
关键词
r-HuEPO; athletes; ethnicity; reticulocytes; erythropoiesis;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives. The detection of recombinant human erythropoietin (r-HuEPO) abuse by athletes remains problematic. The main aim of this study was to demonstrate that the five indirect markers of altered erythropoiesis identified in our earlier work were reliable evidence of current or recently discontinued r-HuEPO use. a subsidiary aim was to refine weightings of the five markers in the initial model using a much larger data set than in the pilot study. A final aim was to verify that the hematologic response to r-HuEPO did not differ between Caucasian and Asiatic subjects. Design and Methods. Recreational athletes resident in Sydney, Australia (Sydney, n = 49; 16 women, 33 men) or Beijing, China (Beijing, n=24; 12 women, 12 men) were randomly assigned to r-HuEPO or placebo groups prior to a 25 day administration phase, injections of r-HuEPO (or saline) were administered double-blind at a dose of 50 IU/kg three times per week, with oral iron (105 mg) or placebo supplements taken daily by all subjects. Blood profiles were monitored during and for 4 weeks after drug administration for hematocrit (Hct), reticulocyte hematocrit (RetHct), percent macrocytes (%Macro), serum erythropoietin (EP0) and soluble transferrin receptor (sTfr), since we had previously shown that these five variables were indicative of r-HuEPO use. Results. The changes in Hct, RetHct, %Macro, EP0 and sTfr in the Sydney trial were qualitatively very similar to the changes noted in our previous administration trial involving recreational athletes of similar genetic origin. Statistical models developed from Fisher's discriminant analysis were able to categorize the user and placebo groups correctly. The same hematologic response was demonstrated in Beijing athletes also administered r-HuEPO. Interpretation and Conclusions. This paper confirms that r-HuEPO administration causes a predictable and reproducible hematologic response. These markers are disturbed both during and for several weeks following r-HuEPO administration. This work establishes an indirect brood test which offers a useful means of detecting and deterring r-HuEPO abuse. Ethnicity did not influence the markers identified as being able to detect athletes who abuse r-HuEPO.
引用
收藏
页码:128 / 137
页数:10
相关论文
共 18 条
  • [1] A novel method utilizing markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes
    Parisotto, R
    Gore, CJ
    Emslie, KR
    Ashenden, MJ
    Brugnara, C
    Howe, C
    Martin, DT
    Trout, GJ
    Hahn, AG
    HAEMATOLOGICA, 2000, 85 (06) : 564 - 572
  • [2] The influence of exercise on serum markers of altered erythropoiesis and the indirect detection models of recombinant human erythropoietin abuse in athletes
    Schumacher, YO
    Temme, J
    Bueltermann, D
    Schmid, A
    Berg, A
    HAEMATOLOGICA, 2003, 88 (06) : 712 - 714
  • [3] Monitoring recombinant human erythropoietin abuse among athletes
    Citartan, Marimuthu
    Gopinath, Subash C. B.
    Chen, Yeng
    Lakshmipriya, Thangavel
    Tang, Thean-Hock
    BIOSENSORS & BIOELECTRONICS, 2015, 63 : 86 - 98
  • [4] Development of reference ranges in elite athletes for markers of altered erythropoiesis
    Sharpe, K
    Hopkins, W
    Emslie, KR
    Howe, C
    Trout, GJ
    Kazlauskas, R
    Ashenden, MJ
    Gore, CJ
    Parisotto, R
    Hahn, AG
    HAEMATOLOGICA, 2002, 87 (12) : 1248 - 1257
  • [5] Analysis of human reticulocyte genes reveals altered erythropoiesis: potential use to detect recombinant human erythropoietin doping
    Varlet-Marie, E
    Audran, M
    Lejeune, M
    Bonafoux, B
    Sicart, MT
    Marti, J
    Piquemal, D
    Commes, T
    HAEMATOLOGICA, 2004, 89 (08) : 991 - 997
  • [6] Human and recombinant erythropoietin stimulate erythropoiesis in the goldfish Carassius auratus
    Taglialatela, R
    Della Corte, F
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 1997, 41 (04): : 301 - 304
  • [7] Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients
    van Iperen, CE
    Gaillard, CAJM
    Kraaijenhagen, RJ
    Braam, BG
    Marx, JJM
    van de Wiel, A
    CRITICAL CARE MEDICINE, 2000, 28 (08) : 2773 - 2778
  • [8] Recombinant human erythropoietin independence in chronic hemodialysis patients: clinical features, iron homeostasis and erythropoiesis
    Kuo, CC
    Lee, CT
    Chuang, CH
    Su, Y
    Chen, JB
    CLINICAL NEPHROLOGY, 2005, 63 (02) : 92 - 97
  • [9] Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in athletes. Blood sampling and doping control
    Souillard, A
    Audran, M
    Bressolle, F
    Gareau, R
    Duvallet, A
    Chanal, JL
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 42 (03) : 355 - 364
  • [10] Recombinant human erythropoietin-induced erythropoiesis regulates hepcidin expression over iron status in the rat
    Ribeiro, Sandra
    Garrido, Patricia
    Fernandes, Joao
    Rocha, Susana
    Rocha-Pereira, Petronila
    Costa, Elisio
    Belo, Luis
    Reis, Flavio
    Santos-Silva, Alice
    BLOOD CELLS MOLECULES AND DISEASES, 2016, 59 : 63 - 70